[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2017 [#3]

Stock

[PHARMA] PHARMANIAGA BHD

Announcement Date

15-Nov-2017

Admission Sponsor

Sponsor

Financial Year

31-Dec-2017

Quarter

30-Sep-2017 [#3]

Profit Trend

QoQ- 12.59%

YoY- -31.04%

Quarter Report

PHARMA's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Cumulative Result
Revenue	2,090,488	2,104,847	1,788,312	1,710,764	1,606,206	1,509,162	1,495,830	5.73%
YoY %	-0.68%	17.70%	4.53%	6.51%	6.43%	0.89%	-	-
Horiz. %	139.75%	140.71%	119.55%	114.37%	107.38%	100.89%	100.00%	-
PBT	49,299	46,609	58,280	53,198	67,948	89,005	87,726	-9.15%
YoY %	5.77%	-20.03%	9.55%	-21.71%	-23.66%	1.46%	-	-
Horiz. %	56.20%	53.13%	66.43%	60.64%	77.45%	101.46%	100.00%	-
Tax	-15,983	-17,323	-19,620	-20,299	-21,189	-20,462	-30,122	-10.01%
YoY %	7.74%	11.71%	3.34%	4.20%	-3.55%	32.07%	-	-
Horiz. %	53.06%	57.51%	65.14%	67.39%	70.34%	67.93%	100.00%	-
NP	33,316	29,286	38,660	32,899	46,759	68,543	57,604	-8.71%
YoY %	13.76%	-24.25%	17.51%	-29.64%	-31.78%	18.99%	-	-
Horiz. %	57.84%	50.84%	67.11%	57.11%	81.17%	118.99%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
NP to SH	33,820	29,379	38,031	32,023	46,435	67,982	57,147	-8.36%
YoY %	15.12%	-22.75%	18.76%	-31.04%	-31.70%	18.96%	-	-
Horiz. %	59.18%	51.41%	66.55%	56.04%	81.26%	118.96%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Tax Rate	32.42%	37.17%	33.67%	38.16%	31.18%	22.99%	34.34%	-
YoY %	-12.78%	10.40%	-11.77%	22.39%	35.62%	-33.05%	-	-
Horiz. %	94.41%	108.24%	98.05%	111.12%	90.80%	66.95%	100.00%	-
Total Cost	2,057,172	2,075,561	1,749,652	1,677,865	1,559,447	1,440,619	1,438,226	6.14%
YoY %	-0.89%	18.63%	4.28%	7.59%	8.25%	0.17%	-	-
Horiz. %	143.04%	144.31%	121.65%	116.66%	108.43%	100.17%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Net Worth	345,040	516,387	522,618	531,892	530,907	534,070	507,513	-6.22%
YoY %	-33.18%	-1.19%	-1.74%	0.19%	-0.59%	5.23%	-	-
Horiz. %	67.99%	101.75%	102.98%	104.80%	104.61%	105.23%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Dividend
Div	26,139	22,168	36,401	33,729	33,667	59,542	41,429	-7.38%
YoY %	17.91%	-39.10%	7.92%	0.18%	-43.46%	43.72%	-	-
Horiz. %	63.09%	53.51%	87.86%	81.41%	81.26%	143.72%	100.00%	-
Div Payout %	77.29%	75.46%	95.71%	105.33%	72.50%	87.59%	72.50%	-
YoY %	2.43%	-21.16%	-9.13%	45.28%	-17.23%	20.81%	-	-
Horiz. %	106.61%	104.08%	132.01%	145.28%	100.00%	120.81%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Equity
Net Worth	345,040	516,387	522,618	531,892	530,907	534,070	507,513	-6.22%
YoY %	-33.18%	-1.19%	-1.74%	0.19%	-0.59%	5.23%	-	-
Horiz. %	67.99%	101.75%	102.98%	104.80%	104.61%	105.23%	100.00%	-
NOSH	261,705	261,229	260,505	259,821	258,979	258,880	258,935	0.17%
YoY %	0.18%	0.28%	0.26%	0.33%	0.04%	-0.02%	-	-
Horiz. %	101.07%	100.89%	100.61%	100.34%	100.02%	99.98%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Ratio Analysis
NP Margin	1.59%	1.39%	2.16%	1.92%	2.91%	4.54%	3.85%	-
YoY %	14.39%	-35.65%	12.50%	-34.02%	-35.90%	17.92%	-	-
Horiz. %	41.30%	36.10%	56.10%	49.87%	75.58%	117.92%	100.00%	-
ROE	9.80%	5.69%	7.28%	6.02%	8.75%	12.73%	11.26%	-
YoY %	72.23%	-21.84%	20.93%	-31.20%	-31.26%	13.06%	-	-
Horiz. %	87.03%	50.53%	64.65%	53.46%	77.71%	113.06%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Per Share
RPS	799.75	807.07	687.79	659.36	620.21	582.96	577.69	5.56%
YoY %	-0.91%	17.34%	4.31%	6.31%	6.39%	0.91%	-	-
Horiz. %	138.44%	139.71%	119.06%	114.14%	107.36%	100.91%	100.00%	-
EPS	12.94	11.26	14.63	12.34	17.93	26.26	22.07	-8.50%
YoY %	14.92%	-23.03%	18.56%	-31.18%	-31.72%	18.99%	-	-
Horiz. %	58.63%	51.02%	66.29%	55.91%	81.24%	118.99%	100.00%	-
DPS	10.00	8.50	14.00	13.00	13.00	23.00	16.00	-7.52%
YoY %	17.65%	-39.29%	7.69%	0.00%	-43.48%	43.75%	-	-
Horiz. %	62.50%	53.12%	87.50%	81.25%	81.25%	143.75%	100.00%	-
NAPS	1.32	1.98	2.01	2.05	2.05	2.063	1.96	-6.37%
YoY %	-33.33%	-1.49%	-1.95%	0.00%	-0.63%	5.26%	-	-
Horiz. %	67.35%	101.02%	102.55%	104.59%	104.59%	105.26%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Adjusted Per Share Value based on latest NOSH - 259,821
RPS	145.05	146.05	124.08	118.70	111.45	104.71	103.79	5.73%
YoY %	-0.68%	17.71%	4.53%	6.51%	6.44%	0.89%	-	-
Horiz. %	139.75%	140.72%	119.55%	114.37%	107.38%	100.89%	100.00%	-
EPS	2.35	2.04	2.64	2.22	3.22	4.72	3.97	-8.36%
YoY %	15.20%	-22.73%	18.92%	-31.06%	-31.78%	18.89%	-	-
Horiz. %	59.19%	51.39%	66.50%	55.92%	81.11%	118.89%	100.00%	-
DPS	1.81	1.54	2.53	2.34	2.34	4.13	2.87	-7.38%
YoY %	17.53%	-39.13%	8.12%	0.00%	-43.34%	43.90%	-	-
Horiz. %	63.07%	53.66%	88.15%	81.53%	81.53%	143.90%	100.00%	-
NAPS	0.2394	0.3583	0.3626	0.3691	0.3684	0.3706	0.3521	-6.22%
YoY %	-33.18%	-1.19%	-1.76%	0.19%	-0.59%	5.25%	-	-
Horiz. %	67.99%	101.76%	102.98%	104.83%	104.63%	105.25%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/09/20	30/09/19	28/09/18	29/09/17	30/09/16	30/09/15	30/09/14	-
Price	4.32	2.44	2.89	4.14	5.58	6.50	4.63	-
P/RPS	0.54	0.30	0.42	0.63	0.90	1.12	0.80	-6.33%
YoY %	80.00%	-28.57%	-33.33%	-30.00%	-19.64%	40.00%	-	-
Horiz. %	67.50%	37.50%	52.50%	78.75%	112.50%	140.00%	100.00%	-
P/EPS	33.39	21.66	19.76	33.54	31.12	24.75	20.98	8.04%
YoY %	54.16%	9.62%	-41.09%	7.78%	25.74%	17.97%	-	-
Horiz. %	159.15%	103.24%	94.18%	159.87%	148.33%	117.97%	100.00%	-
EY	2.99	4.62	5.06	2.98	3.21	4.04	4.77	-7.48%
YoY %	-35.28%	-8.70%	69.80%	-7.17%	-20.54%	-15.30%	-	-
Horiz. %	62.68%	96.86%	106.08%	62.47%	67.30%	84.70%	100.00%	-
DY	2.31	3.48	4.84	3.14	2.33	3.54	3.46	-6.50%
YoY %	-33.62%	-28.10%	54.14%	34.76%	-34.18%	2.31%	-	-
Horiz. %	66.76%	100.58%	139.88%	90.75%	67.34%	102.31%	100.00%	-
P/NAPS	3.27	1.23	1.44	2.02	2.72	3.15	2.36	5.58%
YoY %	165.85%	-14.58%	-28.71%	-25.74%	-13.65%	33.47%	-	-
Horiz. %	138.56%	52.12%	61.02%	85.59%	115.25%	133.47%	100.00%	-

	30/09/20	30/09/19	30/09/18	30/09/17	30/09/16	30/09/15	30/09/14	CAGR
Price Multiplier on Announcement Date
Date	19/11/20	20/11/19	19/11/18	15/11/17	21/11/16	26/11/15	21/11/14	-
Price	5.72	2.21	3.09	3.82	5.70	6.50	4.45	-
P/RPS	0.72	0.27	0.45	0.58	0.92	1.12	0.77	-1.11%
YoY %	166.67%	-40.00%	-22.41%	-36.96%	-17.86%	45.45%	-	-
Horiz. %	93.51%	35.06%	58.44%	75.32%	119.48%	145.45%	100.00%	-
P/EPS	44.21	19.62	21.13	30.95	31.79	24.75	20.16	13.96%
YoY %	125.33%	-7.15%	-31.73%	-2.64%	28.44%	22.77%	-	-
Horiz. %	219.30%	97.32%	104.81%	153.52%	157.69%	122.77%	100.00%	-
EY	2.26	5.10	4.73	3.23	3.15	4.04	4.96	-12.26%
YoY %	-55.69%	7.82%	46.44%	2.54%	-22.03%	-18.55%	-	-
Horiz. %	45.56%	102.82%	95.36%	65.12%	63.51%	81.45%	100.00%	-
DY	1.75	3.85	4.53	3.40	2.28	3.54	3.60	-11.31%
YoY %	-54.55%	-15.01%	33.24%	49.12%	-35.59%	-1.67%	-	-
Horiz. %	48.61%	106.94%	125.83%	94.44%	63.33%	98.33%	100.00%	-
P/NAPS	4.33	1.12	1.54	1.86	2.78	3.15	2.27	11.35%
YoY %	286.61%	-27.27%	-17.20%	-33.09%	-11.75%	38.77%	-	-
Horiz. %	190.75%	49.34%	67.84%	81.94%	122.47%	138.77%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Moomoo MY

Don't Miss Out: Up to USD1,000 in Our Lucky Draw!

Latest Videos

MQ Market Updates - 17 May 2024

MQ Trader

MQ Trading Signals

No trading signals available.

More Trading Signals

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

TASCO

TASCO BERHAD

1000

MPI

MALAYSIAN PACIFIC INDUSTRIES

341

HLIND

HONG LEONG INDUSTRIES BHD

325

PTRANS

PERAK TRANSIT BERHAD

315

YTLPOWR

YTL POWER INTERNATIONAL BHD

162

TOPGLOV

TOP GLOVE CORPORATION BHD

157

GENTING

GENTING BHD

147

PBBANK

PUBLIC BANK BHD

124

INARI

INARI AMERTRON BERHAD

118

GENM

GENTING MALAYSIA BERHAD

116

Daily Stocks

INGENIEU-WB

0.02

+0.015

697,352,800

HSI-CV8

0.165

+0.015

394,105,600

INGENIEU

0.095

+0.02

355,391,100

HSI-HUZ

0.18

-0.025

353,012,500

DNEX

0.44

+0.04

184,010,000

HSI-HU6

0.065

-0.005

158,836,600

INIX-OR

0.02

0.00

141,839,900

REVENUE

0.225

-0.005

115,917,200

TOPGLOV

1.20

0.00

113,307,400

DSONIC

0.525

+0.05

112,593,800

More active Stocks

MPI

36.60

+3.10

911,700

ALLIANZ

23.38

+1.30

93,800

ALLIANZ-PA

24.00

+1.10

12,900

HEIM

25.60

+0.84

514,800

DKSH

5.28

+0.27

512,600

GCB

3.65

+0.26

8,275,600

DLADY

33.00

+0.26

17,900

HLIND

11.08

+0.24

1,187,400

HUMEIND

3.46

+0.23

2,835,500

YTLPOWR

5.39

+0.21

27,494,700

More gainer Stocks

UTDPLT

25.84

-0.36

191,300

PANAMY

19.48

-0.22

72,700

ORIENT

6.97

-0.18

1,220,900

AJI

15.94

-0.18

275,700

PMETAL

5.20

-0.16

8,730,600

KLK

22.40

-0.12

933,500

KUAISHO-C17

0.08

-0.12

58,800

HTPADU

2.41

-0.11

2,460,400

IOICORP-C58

0.04

-0.11

400,000

PARAGON

3.40

-0.10

88,000

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

AmEquities

Affin Hwang

Rakuten Trade

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More